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ABSTRACT 
Objectives: In recent years, lidocaine infusion for pain management during long operations is 
becoming more widespread in anesthesiology practice. However, only a limited number of 
studies have reported the intravenous use of lidocaine for short-term interventions. The aim of 
this study was to investigate the effectiveness of intravenous lidocaine use in pain 
management during colposcopic cervical biopsy and endocervical curettage (ECC). 
Material and methods: Patients between the ages of 18 and 65 years with abnormal 
cytological findings or who were determined to be human papillomavirus (HPV)-positive 
were included in this randomized double-blind study. The lidocaine group (Group L, n = 30) 
was intravenously administered 50 mg dexketoprofen + 1.5 mg/kg lidocaine in 10 mL saline 
for 3 min 30 min before the procedure. The control group (Group C, n = 30) was 
intravenously administered 50 mg dexketoprofen in 10 mL saline for 3 min, 30 min before the 
procedure. During the procedure, pain scores were assessed using the visual analogue scale 
(VAS). In addition, patients, operator satisfaction and duration of procedure were assessed. 
 
Results: There were no differences in the demographic data of the groups. Pain scores during 
biopsy and ECC were significantly lower in Group L than in Group C (p < 0.001). The 
duration of the procedure was significantly shorter in Group L than in Group C (5.00 ± 0.78 
vs 6.12 ± 1.16, respectively; p < 0.001). Patient and operator satisfaction were significantly 
higher in Group L than in Group C (p < 0.001). 
Conclusions: Intravenous lidocaine administration can be used as an alternative approach to 
reduce pain and increase operator and patient satisfaction during colposcopy-directed biopsy 
and ECC procedures in office settings. 
Key words: pain; colposcopy; lidocaine  
 
INTRODUCTION 
 Cervical cancer is prevalent worldwide and ranks second after colon and breast 
cancers in terms of frequency [1]. It has been shown that owing to the screening programs 
launched in underdeveloped countries, the cervical cancer ranking in terms of frequency has 
decreased to the 10th position. Because it has a long precancerous period, various screening 
methods that have been developed can help prevent cervical cancer [2]. The Papanicolaou 
(Pap) smear method used for screening purposes allows the early-stage detection of cancers 
and their precursors [3]. Using colposcopy, which is a more advanced examination technique, 
to shed further light on an abnormal cytological diagnosis is nowadays a frequently used 
approach in treatment management [4]. Colposcopy is a complementary method that is used 
to shed light on abnormal cytological findings. Biopsies are taken from sites that are 
suspected during visualization, and the actual aim of the examination is to exclude invasive 
cervical cancer[4, 5]. 
Colposcopy-directed cervical biopsy is a procedure that is performed on women 
identified as having an abnormal Pap smear or abnormal human papillomavirus (HPV) test 
result [6]. This procedure, which causes varying degrees of pain — from mild to severe — is 
typically performed in office settings without the requirement for anesthesia [7-10]. However, 
the pain caused during the procedure adversely affects patient compliance and decreases the 
effectiveness of the practitioner. For this reason, many studies in the literature have 
investigated the effectiveness of various types of anesthesia and analgesia, including the 
administration of benzocaine gel and topical or submucosal injection of lidocaine [11]. 
In recent years, intravenous lidocaine (IVL) has been used as a postoperative analgesic 
[12]. There is currently no study assessing the effect of IVL on pain during such a short 
procedure as colposcopy. 
The aim of our study was to investigate the effect of the administration of IVL 
primarily on the pain score and secondarily on the satisfaction level of patients and operator 
during colposcopic biopsy, which causes discomfort and pain in patients despite being a short 
procedure. 
 
MATERIALS AND METHODS 
This double-blind, prospective, randomized study was conducted at the gynecologic 
oncology department of our gynecology and obstetrics clinic. The study was initiated after the 
approval of the Local Ethical Committee of Ataturk University Medical Faculty was obtained. 
The patients were informed in detail about the anesthetic procedures, pain scores, and 
colposcopic procedures, and their informed consents were obtained. 
  Patients between the ages of 18 to 65 years who could self-evaluate their pain score 
and who either had an abnormal cytology that required advanced examination or who had 
been identified as HPV-positive were included in the study. Patients with known liver, 
kidney, and advanced-stage cardiac diseases and malignancies; those under the age of 18 
years; those known to be allergic to the medication used in the study; those using chronic pain 
killers; those identified as being pregnant; those with whom communication could not be 
established; and those with no indication for endocervical curettage (ECC) were excluded 
from the study. 
Patients were divided into two groups in a randomized manner using a computer 
software. Study groups and double-blind design are summarized at Table 1. 
The lidocaine group (Group L, n = 30) was administered 50 mg dexketoprofen 
trometamol IV 30 min before the procedure. Anesthesia induction was performed with the 
infusion of 1 mg midazolam (IV) and IV 1.5 mg/kg lidocaine in 10 mL saline in 3 min. 
Similarly, the control group (Group C) was administered 50 mg dexketoprofen 
trometamol IV 30 min before the procedure. Anesthesia induction was performed via infusion 
of 1 mg midazolam (IV) and IV 10 mL saline in 3 min. 
The operators and patients were blinded to information regarding group-specific drug 
infusion. Office settings were arranged in a manner that would meet the requirements for 
administration of anesthetics. Monitoring and resuscitation equipment were made available, 
and it was ensured that the referral system was adequate for any case of emergency. All 
procedures were performed with an anesthetist experienced in office settings. 
Binocular colposcopic examinations were performed by same colposcopist using 
punch biopsy and ECC forceps. 
Study outcomes 
The pain levels of the patients were assessed using visual analogue scale (VAS) scores 
(0: no pain, 10: the worst pain imaginable) at the time of speculum placement, cervical 
biopsy, ECC, and the 10th minute following the procedure. Patient and practitioner 
satisfaction were assessed based on a scale of 1 to 4 (1: poor, 2: moderate, 3: good and 4: 




Statistical analysis was performed using SPSS software version 21.0 (IBM Corp., 
Armonk, New York, USA). The distribution of variables was evaluated for normality using 
the histogram test and Kolmogorov–Smirnov test. Descriptive data were expressed as mean ± 
standard deviation. Normally distributed data consisting of continuous variables were 
analyzed using the Student’s t test. Data without normal distribution were analyzed using the 
Mann–Whitney U test. Categorical variables were analyzed using the χ2 or Fisher’s exact test. 
A value of p <0.05 was considered statistically significant. 
 
RESULTS 
Seventy-six patients were included in the study. Two patients who were examined 
routinely and were found to have a positive B-HCG test, three patients for whom suturation 
was performed on the cervix due to bleeding that occurred after the procedure, and 11 patients 
with no indication of ECC were excluded from the study. Data for a total number of 60 
patients were analyzed. 
Demographic and cytological characteristics of the groups are shown in Table 1. 
Comparisons between patient data for age, height, weight, cytological anomalies, and HPV 
positivity revealed no significant differences (Tab. 2). When compared in terms of cytological 
abnormalities, L-SIL was found to be the most frequent abnormality in both groups. 
Colposcopy indications were observed to be similar for both the groups. All procedures were 
successfully completed without any serious side effects, such as complications, severe 
bleeding, or allergic reaction to lidocaine. 
Paresthesia of the tongue was observed for a short period of time in two patients in the 
lidocaine group, and it resolved on its own within five minutes following the procedure and 
without any additional medication being administered. 
Pain scores of the groups are shown in Table 3. VAS scores during cervical biopsy and 
ECC were significantly lower in Group L compared with Group C (p < 0.001). The duration 
of the procedure was significantly shorter in Group L than in Group C (5.00 ± 0.78 vs 6.12 ± 
1.16, respectively; p < 0.001). Patient and opeerator satisfaction were significantly higher in 
Group L than in Group K (p < 0.001). 
 
DISCUSSION 
The findings from this double-blind, randomized study showed that intravenously-
administered lidocaine can be used as an alternative to other procedures in order to reduce 
pain and increase operator and patient satisfaction during colposcopy-directed biopsies and 
ECC that are performed in office settings. We believe that the duration of the procedure was 
short in Group L owing to patient compliance and comfort of the operator. 
Most women find colposcopy procedures performed in combination with cervical 
biopsies and ECC procedures to be uncomfortable and painful. It is thought that the fear of 
pain is a large obstacle in reaching patients for gynecological procedures. This concern may 
delay the early diagnosis of patients. For clinicians, it is essential to demonstrate the safety 
and effectiveness of various pain control methods. 
The upper vagina, cervix, and lower uterine segment are innerved by parasympathetic 
fibers belonging to the S2 and S4, and the cervix together with uterine blood vessels at the 3- 
and 9-o’clock levels [13]. Because of the visceral innervation of the cervix, it is thought that 
anesthetics are ineffective in reducing pain during CEB [14]. However, many studies in the 
literature describing the effectiveness of anesthetics during colposcopic biopsy procedures 
show contradictory results. Topical anesthetic procedures, nonsteroidal anti-inflammatory 
drugs, administration of submucosal lidocaine for paracervical block, as well as various 
nonpharmacological procedures such as the cough trick technique and hypnosis were reported 
to be effective in many studies [15–17]. The present study examined the administration of 
intravenous lidocaine, which, to the best of our knowledge, has not been used in short 
procedures less than 10 minutes such as colposcopy to date, but whose effectiveness has 
started to be realized in recent years for postoperative analgesia during long term operations 
[18, 19]. In a recent study similar to our design lidocaine infusion during colonoscopy 
procedure resulted in a 50% reduction in propofol dose requirements [20]. Different from our 
study procedure time is approximately thirty minutes for each group. 
Lidocaine is an amide group local anesthetic agent that has been defined as having 
analgesic, anti-hyperallergic, and anti-inflammatory characteristics [12, 21]. Because its half-
life is brief (60–120 min), toxicity symptoms are transient at low doses; however, its analgesic 
effect lasts longer than expected [22, 23]. Intravenously-injected lidocaine has been reported 
to be effective in pain management at outpatient clinics, including operation theaters [12]. 
Studies have demonstrated that lidocaine is effective in non-emergency settings when used for 
perioperative pain and neuropathic pain. Toxicity symptoms of IVL generally occur in a 
manner that can be predicted from its levels in the blood. In addition, when administered as 
rapid infusion or push within a period of few minutes, symptoms can progress rapidly and 
first lead to cardiovascular toxicity. In a review that included 45 randomized controlled 
studies and analyzed over 2500 patients, only 17 of the studies reported undesirable side 
effects, and no serious side effects associated with lidocaine were reported [24]. In a study on 
the use of IVL during neuropathic pain, patients were administered high doses of IVL, such as 
5 mg/kg for 30 min; however, no serious side effects occurred in any of the patients [25, 26]. 
In the present study, the patients were administered IVL at a dose of 1.5 mg/kg, and it was 
observed that paresthesia of the tongue occurred in only two patients. No serious side effects 
were seen in any of the patients. 
The literature suggests using doses not higher than 1.5 mg/kg when administering a 
bolus, and recommends that cardiac and vital findings should be monitored during the 
procedure [22]. To save time in our study, the patients were administered the analgesic 15 min 
before colposcopy while the setting of the procedure was being prepared. 
IVL can be a suitable alternative for pain management in cases where nonsteroidal 
anti-inflammatory drugs (NSAIDs) are ineffective or when they are not used due to their side 
effects and complications. NSAIDs such as ibuprofen are known to reduce pain by inhibiting 
cyclooxygenase and inhibiting prostaglandins in circulation. These drugs have been effective 
in certain gynecological procedures, especially in terms of reducing postoperative pain [13]. 
In a randomized controlled study, Church et al. [27], compared 800 mg ibuprofen and topical 
benzocaine gel administered 30 min before colposcopy, and found no significant difference 
between the two groups in terms of cervical biopsy and ECC. The present study showed that 
NSAID combined with IVL based on multi-model analgesia had superior analgesic effects 
and resulted in superior patient satisfaction compared to the use of NSAIDs alone. 
Because intravenous injection causes discomfort in patients, local anesthetic 
particularly submucosal administered lidocaine is frequently used in minor gynecological 
procedures. However, to ensure safety, it is necessary to prevent toxicity to recognize and 
manage toxicities in a timely manner. The most used local anesthetics in office settings, such 
as lidocaine or bupivacaine, are associated with fewer allergic reactions. For paracervical 
block, a dose of 200 mg lidocaine (20 mL of 1% lidocaine) is used, which is below the 
toxicity threshold [13]. In a study in which paracervical block was performed with an 
injection of 0.5 mL of 1% lidocaine, Oyama et al. [28] detected a significant decrease in pain 
scores. In a study by Schmid et al. [15], the cough trick technique, a nonpharmacological 
method, was compared with injection of 1% lidocaine to the cervix and no statistically 
significant difference between the two methods was found. However, Naki et al. [16], showed 
that the cough trick technique was not effective compared with the control group. However, 
because injection itself can cause additional pain and hemorrhage, many studies in the 
literature have discussed topical agents to avoid the disadvantages associated with infiltration 
anesthesia in colposcopic procedures. In a study that compared the use of local anesthetic 
agents in the form of sprays with placebos, no significant reduction in pain was identified [8]. 
However, in another study, the use of lidocaine in the form of a spray was compared with 
paracervical block during loop electrosurgical excision procedure, and it was reported that LS 
could be used instead of paracervical block for pain management [29].  
The procedures performed in office settings have two objectives: completing the 
procedure successfully safely and facilitating patient comfort. Additionally, patient comfort 
influences the clinician’s ability to complete the procedure in a safe and effective manner. The 
safe use of anesthesia in office settings, the varying reactions from the patients to these drugs, 
and the fast fluctuations in sedation levels require focused planning. Therefore, the use of 
anesthesia in office settings necessitate space-specific arrangements, advanced life support 
training for practitioners, availability of cardiac monitoring and resuscitation equipment, and 
an experienced team. 
 The limitations of the present study include, first, the short-term administration of 
intravenous lidocaine and the fact that an adequate plasma level could not be reached. It might 
have been necessary to measure the plasma level of lidocaine as well. Second, no other 
sedative and opioid agent except midazolam was used in any of the patients to ensure that all 
of the patients could assess their VAS scores consciously. A study including opioid and 
sedative use could have made a more objective evaluation. 
 Under present conditions, intravenous lidocaine can be accepted as an alternative 
method for pain management during colposcopy. To ensure its use in office settings, there is a 
need for higher numbers of prospective randomized studies conducted with more patients that 
investigate its efficacy and safety. Studies that assess the dose, infusion time, or drug 
interactions might be helpful to determine safe threshold values. 
 In conclusion, for the management of pain that develops during gynecological 
procedures performed in office settings, IVL can be used to reduce pain and improve patient 
and operator satisfaction. 
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Table 1. Study groups 
 Group Control  Group Lidocaine  
Sedatives 1 mg midazolam 1 mg midazolam 
NSAID’s (30 minutes before 
procedure) 
100 mL normal saline + 50 
mg dexketoprofen 
trometamol   
100 mL normal saline + 50 mg 
dexketoprofen trometamol   
Intravenous solution (3 
minutes before procedure) 
10 mL normal saline 
10 mL (normal saline + 1.5 mg/kg 
lidocaine) 
NSAID — nonsteroidal anti-inflammatory drugs 
 
Table 2. Demographic data of study 
 Group Control (n = 
30) 
Group Lidocaine (n 
= 30) 
p 
Age [year]  37.10 ± 7.37  36.53 ± 6.93 0.760a 
Weight [kg] 65.80 ± 11.74 68.53 ± 10.03 0.066a 
Height [cm] 158.47 ± 5.83  161.10 ± 5.03  0.336a 
Procedure time [min] 
6.12 ± 1.16 5.00 ± 0.78 
< 
0.001b 
HPV (yes/no) 10/20 14/16 0.292c 
Cervical Cytology;  ASC-US 10 8 
0.878c 
 H-SIL 2 4 
 L-SIL 11 11 
 ASC-H 2 3 
 Normal 5 4 
Values are presented as mean ± standart deviation or number; HPV — human papilloma 
virus; ASC-US — undetermined significance; H-SIL — high grade squamous intraepithelial 
lesion; L-SIL — low grade squamous intraepithelial lesion; ASC-H — can not exclude high 
grade lesion; aIndependent Sample t test; bMann Whitney-U test; cChi-square test 
 
Table 3. Pain scores, patient and operator satisfaction 
Values are presented as median (percentage 25-75) or number (percentage), VAS — visual 




  Group Control 
(n = 30) 




Speculum Placement 0 (0–1) 0 (0–1) 0.421a 
During Biopsy 4 (3–4) 2 (1–3) < 0.001b 
Endocervical curettage  5 (4–6) 2.5 (2–3) < 0.001b 
After Procedure 0 (0–0) 0 (0–0) 1.000a 
Patient 
Satisfaction 
Poor 17 2 
< 0.001c 
Moderate 11 8 
Good 2 12 
Excellent 0 8 
Operator 
Satisfaction 
Poor 13 0 
< 0.001c 
Moderate 14 7 
Good 3 9 
Excellent 0 14 
